{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:47:10Z","timestamp":1767919630543,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Facial Plastic Surgery Clinics of North America"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.fsc.2013.04.003","type":"journal-article","created":{"date-parts":[[2013,9,7]],"date-time":"2013-09-07T12:45:56Z","timestamp":1378557956000},"page":"335-342","source":"Crossref","is-referenced-by-count":13,"title":["Nonsurgical Therapy for Hair Loss"],"prefix":"10.1016","volume":"21","author":[{"given":"Aron G.","family":"Nusbaum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul T.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard P.","family":"Nusbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.fsc.2013.04.003_bib1","first-page":"1412","article-title":"Update on the pathogenesis, genetics and medical treatment of patterned hair loss","volume":"9","author":"Schweiger","year":"2010","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"4","key":"10.1016\/j.fsc.2013.04.003_bib2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jaad.2008.07.001","article-title":"Medical treatments for male and female pattern hair loss","volume":"59","author":"Rogers","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.fsc.2013.04.003_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1346-8138.2011.01361.x","article-title":"Guidelines for the management of androgenetic alopecia (2010)","volume":"39","author":"Tsuboi","year":"2012","journal-title":"J\u00a0Dermatol"},{"issue":"6","key":"10.1016\/j.fsc.2013.04.003_bib4","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1096\/fj.07-099424","article-title":"Human hair follicles contain two forms of ATP-sensitive potassium channels, only one of which is sensitive to minoxidil","volume":"22","author":"Shorter","year":"2008","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.fsc.2013.04.003_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0738-081X(88)90084-3","article-title":"The stumptailed macaque as a model for androgenetic alopecia: effects of topical minoxidil analyzed by use of the folliculogram","volume":"6","author":"Brigham","year":"1988","journal-title":"Clin Dermatol"},{"issue":"4","key":"10.1016\/j.fsc.2013.04.003_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0738-081X(88)90086-7","article-title":"Histologic response to topically applied minoxidil in male-pattern alopecia","volume":"6","author":"Abell","year":"1988","journal-title":"Clin Dermatol"},{"issue":"5 Pt 1","key":"10.1016\/j.fsc.2013.04.003_bib7","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0190-9622(99)70006-X","article-title":"Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment","volume":"41","author":"Price","year":"1999","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.fsc.2013.04.003_bib8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1067\/mjd.2002.124088","article-title":"A\u00a0randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men","volume":"47","author":"Olsen","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.fsc.2013.04.003_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1067\/mjd.2002.119104","article-title":"Allergic contact dermatitis to topical minoxidil solution: etiology and treatment","volume":"46","author":"Friedman","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.fsc.2013.04.003_bib10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/00128071-200708050-00003","article-title":"Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial","volume":"8","author":"Shin","year":"2007","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.fsc.2013.04.003_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1468-3083.2003.00621.x","article-title":"Hypertrichosis in females applying minoxidil topical solution and in normal controls","volume":"17","author":"Dawber","year":"2003","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.fsc.2013.04.003_bib12","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jaad.2010.09.724","article-title":"A\u00a0randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women","volume":"65","author":"Blume-Peytavi","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.fsc.2013.04.003_bib13","first-page":"1404","article-title":"The role of inflammation and immunity in the pathogenesis of androgenetic alopecia","volume":"10","author":"Magro","year":"2011","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"4 Pt 1","key":"10.1016\/j.fsc.2013.04.003_bib14","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0190-9622(98)70007-6","article-title":"Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group","volume":"39","author":"Kaufman","year":"1998","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.fsc.2013.04.003_bib15","first-page":"555","article-title":"Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss","volume":"41","author":"Roberts","year":"1999","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.fsc.2013.04.003_bib16","first-page":"1747","article-title":"Persistent sexual side effects of finasteride for male pattern hair loss","volume":"8","author":"Irwig","year":"2011","journal-title":"J\u00a0Sex Med"},{"issue":"3","key":"10.1016\/j.fsc.2013.04.003_bib17","first-page":"872","article-title":"Adverse side effects of 5alpha-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients","volume":"8","author":"Traish","year":"2011","journal-title":"J\u00a0Sex Med"},{"issue":"18","key":"10.1016\/j.fsc.2013.04.003_bib18","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/jnci\/djm117","article-title":"Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial","volume":"99","author":"Lucia","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"18","key":"10.1016\/j.fsc.2013.04.003_bib19","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/jnci\/djm130","article-title":"Detection bias due to the effect of finasteride on prostate volume: a modeling approach for analysis of the Prostate Cancer Prevention Trial","volume":"99","author":"Cohen","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"5 Pt 1","key":"10.1016\/j.fsc.2013.04.003_bib20","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1067\/mjd.2000.107953","article-title":"Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia","volume":"43","author":"Price","year":"2000","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.fsc.2013.04.003_bib21","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/archderm.142.3.298","article-title":"Finasteride treatment of female pattern hair loss","volume":"142","author":"Iorizzo","year":"2006","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.fsc.2013.04.003_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1468-3083.2010.03758.x","article-title":"5 mg\/day finasteride treatment for normoandrogenic Asian women with female pattern hair loss","volume":"25","author":"Yeon","year":"2011","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.fsc.2013.04.003_bib23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0015-0282(02)04551-X","article-title":"Treatment of hyperandrogenic alopecia in women","volume":"79","author":"Carmina","year":"2003","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.fsc.2013.04.003_bib24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2133.2005.06218.x","article-title":"Treatment of female pattern hair loss with oral antiandrogens","volume":"152","author":"Sinclair","year":"2005","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.fsc.2013.04.003_bib25","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1210\/jc.2003-030330","article-title":"Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor","volume":"89","author":"Clark","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.fsc.2013.04.003_bib26","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jaad.2006.05.007","article-title":"The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride","volume":"55","author":"Olsen","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.fsc.2013.04.003_bib27","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaad.2009.09.018","article-title":"Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study","volume":"63","author":"Eun","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.fsc.2013.04.003_bib28","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1210\/jc.2006-2203","article-title":"The effect of 5alpha-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men","volume":"92","author":"Amory","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.fsc.2013.04.003_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1440-0960.2012.00909.x","article-title":"Combination therapy with finasteride and low-dose dutasteride in the treatment of androgenetic alopecia","volume":"54","author":"Boyapati","year":"2013","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.fsc.2013.04.003_bib30","first-page":"1","article-title":"Mechanisms of low level light therapy","volume":"6140","author":"Hamblin","year":"2006","journal-title":"Proc SPIE"},{"issue":"5","key":"10.1016\/j.fsc.2013.04.003_bib31","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1524-4725.2005.31168","article-title":"Hair growth induced by diode laser treatment","volume":"31","author":"Bernstein","year":"2005","journal-title":"Dermatol Surg"},{"issue":"3","key":"10.1016\/j.fsc.2013.04.003_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.33589\/20.3.0083","article-title":"An interview with Professor Michael Hamblin","volume":"20","author":"Farjo","year":"2010","journal-title":"Hair Transplant Forum Int\u2019l"},{"issue":"5","key":"10.1016\/j.fsc.2013.04.003_bib33","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/00044011-200929050-00001","article-title":"HairMax LaserComb laser phototherapy device in the treatment of male androgenetic alopecia: a randomized, double-blind, sham device-controlled, multicentre trial","volume":"29","author":"Leavitt","year":"2009","journal-title":"Clin Drug Investig"},{"issue":"126","key":"10.1016\/j.fsc.2013.04.003_bib34","doi-asserted-by":"crossref","first-page":"126ra134","DOI":"10.1126\/scitranslmed.3003122","article-title":"Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia","volume":"4","author":"Garza","year":"2012","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.fsc.2013.04.003_bib35","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jaad.2011.05.026","article-title":"A\u00a0randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia","volume":"66","author":"Blume-Peytavi","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.fsc.2013.04.003_bib36","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1468-3083.2012.04535.x","article-title":"Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation","volume":"27","author":"Moftah","year":"2012","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.fsc.2013.04.003_bib37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.33589\/17.4.117","article-title":"Improving the revascularization of transplanted hair follicles through up-regulation of angiogenic growth factors","volume":"17","author":"Rinaldi","year":"2005","journal-title":"Hair Transplant Forum Int\u2019l"},{"issue":"4","key":"10.1016\/j.fsc.2013.04.003_bib38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.33589\/17.4.131","article-title":"Preliminary experience and extended applications for the use of autologous platelet-rich plasma in hair transplantation surgery","volume":"17","author":"Greco","year":"2007","journal-title":"Hair Transplant Forum Int\u2019l"},{"issue":"6","key":"10.1016\/j.fsc.2013.04.003_bib39","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1097\/01.prs.0000239560.29172.33","article-title":"The role of platelet plasma growth factors in male pattern baldness surgery","volume":"118","author":"Uebel","year":"2006","journal-title":"Plast Reconstr Surg"},{"issue":"7 Pt 1","key":"10.1016\/j.fsc.2013.04.003_bib40","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1524-4725.2012.02394.x","article-title":"Autologous platelet-rich plasma: a potential therapeutic tool for promoting hair growth","volume":"38","author":"Li","year":"2012","journal-title":"Dermatol Surg"},{"issue":"2","key":"10.1016\/j.fsc.2013.04.003_bib41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.33589\/18.2.0051","article-title":"A\u00a0single-blinded, randomized controlled study of the use of autologous platelet rich plasma (PRP) as a medium to reduce scalp hair transplant adverse effects","volume":"18","author":"Reese","year":"2008","journal-title":"Hair Transplant Forum Int\u2019l"},{"issue":"12","key":"10.1016\/j.fsc.2013.04.003_bib42","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1111\/j.1524-4725.2011.02123.x","article-title":"Enhanced effect of platelet-rich plasma containing a new carrier on hair growth","volume":"37","author":"Takikawa","year":"2011","journal-title":"Dermatol Surg"}],"container-title":["Facial Plastic Surgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064740613000588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064740613000588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T18:48:20Z","timestamp":1646506100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064740613000588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1064740613000588"],"URL":"https:\/\/doi.org\/10.1016\/j.fsc.2013.04.003","relation":{},"ISSN":["1064-7406"],"issn-type":[{"value":"1064-7406","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}